This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
nearly tripled between 2016 and 2019, according to new national estimates from a cohort study in JAMA Network Open. Over 48,000 people got some type of gender-affirming surgery between 2016-2020, with a slight decrease in the number of surgeries performed in 2020, likely because of the pandemic.
In 2016, a number of states filed what eventually became the first in a trio of lawsuits against many of the largest generic companies for allegedly coordinating efforts to fix and maintain prices for dozens of medications to treat a variety of ailments.
I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of only six contracts with NCI to conduct Phase 1 clinical trials from 1990-1995, and serving as co-chair of NCI’s Investigational Drug Steering Committee from 2005-2008.
The task force’s newest advice , which gives a “B” grade in favor of routine mammograms for women in their 40s, reverses its 2016 statement saying the test should be optional for such women. And that 2016 opinion conflicted with earlier task force recommendations.
With some of the highest obesity levels in South America, the country had begun enforcing strict regulations on Frosted Flakes and other foods that exceeded set thresholds for sugar, calories, salt, or saturated fat in 2016. Read the rest…
In 2016, Ionis won approval for an infusion called Spinraza. Yet there were many older children and even some adults with debilitating but more mild disease who might be treated. Much Much has changed, though, since Zolgensma’s earliest trials. After Zolgensma was approved, Roche won approval for a pill.
The data, gathered in 2022, is part of the agency’s Disability and Health Data System , which has annual state and national-level data stretching back to 2016. This comorbidity looms large for many disabled communities as another surge in Covid cases sweeps the country.
I first met Wes Ely in 2016, when I wrote about ICU delirium and Ely’s attempts, as a critical-care physician at Vanderbilt University Medical Center, to urge fellow health care workers to rethink the use of heavy sedation in ICUs. Well, a lot’s happened since 2016.
As of last October, the agency had received more than 500 drug submissions with AI components going back to 2016, with a large number in the areas of oncology, neurology, and gastroenterology. The guidance comes as drug regulatory submissions citing AI have increased exponentially.
The report , which was released in March but received little if any public attention, examined drug spending between 2016 and 2021 within the health plan that covers more than 200,000 unionized mail carriers and post office workers, as well as retirees.
In 2016, the Arkansas Legal Aid Center was flooded with calls. People on a Medicaid program that provided in-home care assistance were having their caregiving hours cut. Reducing the hours for somebody with quadriplegia or cerebral palsy was devastating, said Kevin De Liban, an attorney with the organization at the time.
Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. The issue isn’t new.
In the eight years between the drug’s spectacular 2016 debut on the cover of Nature and its ignominious end , Biogen made multiple, really bad decisions. Its decision, the company explained, is not a response to new data about the drug’s safety or efficacy, but instead “a reprioritization of resources.”
Philips Respironics, a subsidiary of Philips, allegedly gave out masks from 2016 to 2021. The masks, according to a press release from the Department of Justice, were used to diagnose and treat sleep disorders. The case never went to court. The DOJ says Philips violated the Anti-Kickback Statute as well as the False Claims Act.
The company earned its first clearance from the Food and Drug Administration in 2016 , and went public in 2019 at a share price of $17. According to a press statement, Shockwave has treated 400,000 patients with this method globally.
Intarcia started developing its lead therapy, a small, skinny bar implanted under the skin, for type 2 diabetes patients in 2016. The agency is not bound to advisory panel decisions, though it tends to follow their advice.
The appointment follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina’s CEO since 2016. Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO.
They examined data spanning January 2016 through June 2021 at 619 U.S. “There is an urgent need to understand why clinicians at hospitals with access to newer agents do not always prefer newer agents,” the researchers wrote in the Annals of Internal Medicine. Continue to STAT+ to read the full story…
billion in 2016. Since it began more than 30 years ago, the program has ballooned and fed into the national clash over the cost of medicines. Some $38 billion in prescription medications were purchased under the 340B program in 2020, for instance, which was up from $16.2 Continue to STAT+ to read the full story…
The original guidelines , issued in 2016, helped further drive down opioid prescribing levels that had been in decline since 2012, as the country grappled with its legacy of overprescribing that contributed to the overdose epidemic.
After his death in 2016, his mother, Paula, launched a campaign to mandate training on intellectual disability and autism for health care workers. A few days later, Oliver suffered a lethal neurological side effect. A week later, he was taken off life support. An inquest into his death found that the drug had led to the rapid deterioration.
Approximately six months later, on Halloween night 2016, a young man in Rhode Island died of a drug overdose. At age five, he needed a second transplant, but his mother was told it was unlikely that a child’s liver of suitable size would become available in time.
In 2016, when Simmone Taitt had her first pregnancy loss, she was very well insured, had a high-paying job as a tech executive, and had access to one of the top OB-GYNs in New York City. When Black people receive maternal care, they are often not treated the same as white people.
This latest revision, known as the DSM-5-TR, was prepared between 2016 and 2019, and published in 2022. -based physicians who helped assemble a recent revision of the Diagnostic and Statistical Manual of Mental Disorders, which is often referred to as the bible of psychiatry.
They’re investing in insurance brokerages, marketers, in-home assessment companies, and “insurtechs,” the report said, based on a new analysis of deals in the space since 2016.
Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.
When he was hospitalized in August 2016, hospital staff used a needle to drain 7 liters of fluid from his abdomen. The final years of Carl Hoffer’s life were, in his words, “living hell.” ” His legs were so swollen they’d crack and leak white fluid. Read the rest…
In 2016, the 21 st Century Cures Act required that the U.S. make progress toward interoperability, which it defined as “all electronically accessible health information” to be accessed, exchanged and used “without special effort on the part of the user.”
Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work. The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history. Then, it announced plans to re-acquire the firm for $7.1
Although that annual growth rate is the lowest since 2016, the private plans now catch roughly half of the entire Medicare population. million seniors and people with disabilities are now enrolled in a private Medicare plan, known as Medicare Advantage, according to new federal government data analyzed by STAT. That total is 7.1%
In 2016, a trial for a hormonal male birth control pill was halted after men reported side effects including acne and mood swings — though such side effects are also experienced by women on various hormonal contraceptives. Attempts to change the status quo have been scarce and unsuccessful.
Directly observed therapy — where a health professional watches someone take a medication — has been the standard of care for tuberculosis treatment in the United States since 2016. Now DOT, as it’s called, has an approved video alternative.
In 2016, 340B sales were $16.2 Since it began 30 years ago, the program has ballooned and fed into the national clash over the cost of medicines. Some $44 billion in medicines were purchased under the 340B program in 2021, which was up from $38 billion the previous year. Continue to STAT+ to read the full story…
But Bristol stumbled in 2016 when its immunotherapy Opdivo failed to help patients with non-small cell cancer more than chemotherapy. Opdivo remained a big seller, but its failure allowed Merck’s rival Keytruda to move into position to become the best-selling medicine in the world.
The final rule marks a major expansion of EPA regulation under a landmark 2016 law that overhauled regulations governing tens of thousands of toxic chemicals in everyday products, from household cleaners to clothing and furniture. Read the rest…
The study is the most comprehensive Medicaid analysis of opioid addiction to date, analyzing a national claims dataset with 76 million patient data points between 2016 and 2018. A new study published Friday in JAMA Health Forum drives home how lack of access to lifesaving medications could contribute to these preventable deaths.
Good Therapeutics, a private company that raised just $30 million in venture financing since its 2016 foundation, said Wednesday it had signed a deal to sell itself to Roche for $250 million without ever running a clinical trial.
Thanks to changes in tax law six years ago, several of the largest pharmaceutical companies saw their tax rates fall substantially, but they also reported that most of their profits were shifted offshore in an effort to avoid paying U.S. taxes, according to a memo by a U.S. Senate Committee. in 2020, down from 19.6%
The FDA previously moved to withdraw approval of the antibiotic in 2016 over carcinogenicity , but the manufacturer, Phibro Animal Health, fought the effort by arguing, in part, that its drug is medically necessary.
billion over the next few years to be channeled to the Cancer Moonshot, a mission to end cancer that he first launched as vice president in 2016, less than a year after his son Beau’s death from brain cancer. In a long-awaited 2024 budget proposal released Thursday, the president asked for a combined $3.6
Founded in 2016, BehaVR is currently pursuing multiple avenues for commercializing therapeutic virtual reality, including partnerships with Japanese drugmaker Sumitomo Pharma and musculoskeletal care conglomerate Confluent Health.
246
246
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content